Other Income, Net

12 Months Ended

Mar. 31, 2022

Other Nonoperating Income (Expense) [Abstract]

Other income, net consists of the following:


	Years Ended March 31,
(In millions)	2022		2021		2020
Interest income	$	10	$	12	$	49
Equity in earnings, net (1)	43		48		36
Net gains on investments in equity securities (2)	98		133		17
Actuarial gains (losses) from pension plans (3)	5		—		(127)
Other, net (4)	103		30		37
Total	$	259	$	223	$	12

(1)Primarily recorded within the Company’s International segment.

(2)Represents net realized and unrealized gains on the Company’s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, “Fair Value Measurements” and Financial Note 21, “Segments of Business” for more information.

(3)The year ended March 31, 2020 includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, “Pension Benefits” for more information.

(4)Includes a gain of $42 million for the year ended March 31, 2022 as part of the completed sale of the Company’s 30% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.